Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Johnson & Johnson : Wall St drags on Boeing and Chinese data

share with twitter share with LinkedIn share with facebook
share via e-mail
10/21/2019 | 01:12am EST

WALL Street fell on Friday as negative headlines about Johnson & Johnson and Boeing, along with bleak economic data from China, soured investor risk appetite and offset generally positive corporate earnings.

All three major US stock averages ended the session in the red, but the S&P 500 and the Nasdaq posted weekly gains. The blue-chip Dow was nominally lower than the close a week earlier.

Boeing and Johnson & Johnson shares led both the S&P 500's and the Dow's declines.

Boeing dropped 6.8 per cent after Reuters reported that text messages between two employees suggested the plane maker misled the US Federal Aviation Administration about the safety of the grounded 737 Max aircraft.

Johnson & Johnson announced it would recall baby powder in the United States after regulators found trace amounts of asbestos in a sample, sending its shares falling 6.2 per cent.

Growth of China's GDP slowed to its weakest pace in nearly 30 years as the bruising trade war with the US took its toll, stoking fears of slowdown contagion.

The International Monetary Fund lowered its forecast for global growth this year to three per cent, which mark the slowest expansion since the financial crisis.

Third-quarter earnings season has hit full stride, with 73 companies in the S&P 500 having reported. Of those, 83.6 per cent have come in above average estimates, according to Refinitiv data.

The Dow Jones Industrial Average fell 255.68 points, or 0.95 per cent, to 26,770.2, the S&P 500 lost 11.75 points, or 0.39 per cent, to 2,986.2 and the Nasdaq Composite dropped 67.31 points, or 0.83 per cent, to 8,089.54.

Of the 11 major sectors in the S&P 500, seven closed in the red, with tech, communications services and industrials suffering the biggest percentage declines.

(c) 2019 City A.M., source Newspaper

Stocks mentioned in the article
ChangeLast1st jan.
BOEING COMPANY (THE) 1.34% 371.34 Delayed Quote.15.01%
JOHNSON & JOHNSON 1.19% 138.07 Delayed Quote.5.34%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on JOHNSON & JOHNSON
10:56aThe Best-Managed Companies of 2019 -- and How -2-
10:56aThe Best-Managed Companies of 2019 -- and How They Got That Way -- Journal Re..
11/21JOHNSON & JOHNSON : Australian judge finds Johnson & Johnson 'negligent' in vagi..
11/21JOHNSON & JOHNSON : Oklahoma attorney general to appeal judge's opioid ruling
11/21JOHNSON & JOHNSON : Women win landmark class action against Johnson & Johnson in..
11/19GENMAB : EC Approves Expanded Darzalex Use in Multiple Myeloma
11/18JOHNSON & JOHNSON : Janssen Leverages Wearable Technology to Reimagine Clinical ..
11/18J&J Rushed to Test Safety of Baby Powder -- WSJ
11/17JOHNSON & JOHNSON : J&J Rapidly Tested Its Baby Powder After Asbestos Finding --..
11/16Johnson & Johnson Opioid Verdict Cut -- WSJ
More news
Financials (USD)
Sales 2019 82 172 M
EBIT 2019 25 637 M
Net income 2019 17 334 M
Debt 2019 6 823 M
Yield 2019 2,72%
P/E ratio 2019 21,1x
P/E ratio 2020 18,6x
EV / Sales2019 4,51x
EV / Sales2020 4,23x
Capitalization 363 B
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 149,90  $
Last Close Price 138,07  $
Spread / Highest target 25,3%
Spread / Average Target 8,57%
Spread / Lowest Target -6,57%
EPS Revisions
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
Charles O. Prince Independent Director
William David Perez Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON5.34%359 093
ROCHE HOLDING AG24.42%260 775
MERCK AND COMPANY11.84%217 580
PFIZER-13.54%208 858
NOVARTIS20.58%204 460
AMGEN17.03%135 367